Lansing-based Neogen has acquired International Diagnostic Systems Corp. (IDS), opening new European markets to the food and animal safety company. Neogen makes test kits to detect drugs in food including meat and seafood, and animal feed. Its tests also detect drugs in forensic and animal samples.
Based in St. Joseph, IDS has been in business for more than 20 years, and offers approximately 40 products. In addition to significant sales in the United States, IDS has distribution in France, Italy, Spain, Germany, and China.
IDS recorded revenues of approximately $2 million in its most recently completed fiscal year. Terms of the acquisition were not disclosed.
A part of IDS's operations will be relocated to Neogen's Lexington, Ky., plant. The company's research and development operations, and key IDS employees, will remain in IDS's Michigan offices.
"We are pleased to have several employees with many years of experience join Neogen," says Lon Bohannon, Neogen's president.
In the late 1980s, IDS began selling drug monitoring products to the horse and dog racing industry. In recent years, IDS expanded into the human forensics drug testing market.
Neogen’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns.
Its Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Source: Neogen
Gretchen Cochran, Innovation & Jobs editor, may be reached here.
All Photographs © Dave Trumpie
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.